We invest in visionary science start-ups.

Our portfolio
Pitch your idea

We share our founders' passion for transformative technologies

We are


Our roots are in


We invest across



across life science, software and

We provide follow-on funding up to

€ 4m

In a nutshell

> 200

people work in
our portfolio

Our current
fund is

€ 45m

Gateway to an
including high
tech facilities



in our portfolio

We have strong ties to

leading edge

at the Institute of Science and
Technology, Austria

Our companies have raised

> € 100mn

in grants and equity funding.

Our starting point is a strong founding team with grit

We help you transition from a science project to a commercial venture.

About us

We focus on your needs.

We're here for you every step of the way, from negotiating university agreements to navigating corporate partnerships.

We let you focus on your needs.

Minimize distractions and let our expertise in finance, IP, grant acquisition, and HR help your business thrive.

We are transparent. Here is our term sheet.

Read our term sheet

We are scientists & investors. And a whole lot more.

Photo of our team

Bringing the two forces together is our mission. Our team’s unparalleled expertise in both science and business and our broad network turns ideas into reality.

Meet the team

Our Portfolio

Company in the Spotlight

By means of synthetic biology and genetic code expansion Valanx has developed a novel site-specific protein conjugation platform that allows precise control over conjugation site and number of conjugations on the protein of interest. Based on this platform Valanx is developing a number of cutting-edge biologics towards potential treatments for various indications.

Read more


Prewave, the supply chain risk management and compliance platform used by hundreds of clients, secured 18m Euro in funding in a Series A+ by leading European VC Creandum.

Read more

April 19 2023 – Around the Institute of Science and Technology Austria (ISTA) a new innovation ecosystem is growing, which is changing the innovation and spin off landscape in Austria and beyond.

Read more

The Austrian deep tech startup Sarcura closes an oversubscribed €7M Seed Plus funding round to develop a next-generation cell therapy manufacturing platform.

Read more

Newly founded Neurotech startup Brightmind.AI, led by founders Florian Lerchbammer-Kreith and Tamara Gerbert, has announced a foundational pre-seed investment in the company by venture fund IST cube.

Read more

If there’s a breakthrough brewing in your brain, reach out to us.

Pitch your idea

About You

About Your Startup (regardless of incorporation status)

By submitting this form you agree to our Privacy Policy